MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 204 filers reported holding MEDICINES CO in Q4 2016. The put-call ratio across all filers is 2.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $231,825,000 | +1.4% | 6,830,448 | +12.8% | 0.04% | -8.5% |
Q3 2016 | $228,524,000 | +21.0% | 6,055,222 | +7.8% | 0.05% | +11.9% |
Q2 2016 | $188,878,000 | +8.5% | 5,616,350 | +2.5% | 0.04% | +5.0% |
Q1 2016 | $174,029,000 | -13.6% | 5,477,774 | +1.5% | 0.04% | -13.0% |
Q4 2015 | $201,529,000 | +1.7% | 5,397,125 | +3.4% | 0.05% | -9.8% |
Q3 2015 | $198,111,000 | +32.5% | 5,218,933 | -0.1% | 0.05% | +41.7% |
Q2 2015 | $149,470,000 | +2.2% | 5,224,412 | +0.1% | 0.04% | +2.9% |
Q1 2015 | $146,210,000 | +8.3% | 5,218,054 | +6.9% | 0.04% | +6.1% |
Q4 2014 | $135,066,000 | +36.2% | 4,881,321 | +9.9% | 0.03% | +17.9% |
Q3 2014 | $99,158,000 | -22.8% | 4,442,546 | +0.5% | 0.03% | -22.2% |
Q2 2014 | $128,419,000 | +2.0% | 4,419,092 | -0.3% | 0.04% | -2.7% |
Q1 2014 | $125,929,000 | -25.9% | 4,431,011 | +0.7% | 0.04% | -28.8% |
Q4 2013 | $169,946,000 | +20.6% | 4,400,456 | +4.7% | 0.05% | +8.3% |
Q3 2013 | $140,900,000 | +36.4% | 4,203,447 | +25.2% | 0.05% | +26.3% |
Q2 2013 | $103,300,000 | – | 3,358,242 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,752,000 | $58,919,000 | 16.72% |
Antipodean Advisors LLC | 467,223 | $15,713,000 | 9.50% |
BRIDGER MANAGEMENT, LLC | 2,412,501 | $81,132,000 | 5.24% |
Signpost Capital Advisors, LP | 219,998 | $7,399,000 | 3.90% |
Camber Capital Management LP | 2,000,000 | $67,260,000 | 3.25% |
Partner Investment Management, L.P. | 50,808 | $1,709,000 | 2.80% |
ASHFORD CAPITAL MANAGEMENT INC | 368,392 | $12,389,000 | 2.77% |
PFM Health Sciences, LP | 2,618,754 | $88,069,000 | 2.66% |
IMA Wealth, Inc. | 99,569 | $3,300,000 | 2.07% |
First Light Asset Management, LLC | 125,889 | $4,234,000 | 1.96% |